PhRMA appreciates the opportunity to offer recommendations to achieve our shared goal of modernizing coverage and payment policies to support patient access to new medical advances. Our comments address opportunities to advance the use of digital health tools and real-world evidence (RWE) as well as to promote interoperability and evolve coverage and payment policies for breakthrough therapies, including potentially curative therapies.

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.